<DOC>
	<DOCNO>NCT01839019</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability escalate single dos ODM-102 healthy volunteer</brief_summary>
	<brief_title>Safety Tolerability Study With Single Ascending Doses ODM-102</brief_title>
	<detailed_description />
	<criteria>Written inform consent ( IC ) obtain . Good general health ascertain detailed medical history physical examination . Finnishspeaking male 18 45 year age ( inclusive ) . Body mass index ( BMI ) 18.030.5 kg/m2 ( inclusive ) . Weight 55.0100.0 kg ( inclusive ) . Suspected poor compliance inability communicate well investigator . Veins unsuitable repeated venipuncture . Evidence clinically significant cardiovascular , renal , hepatic , haematological , gastrointestinal , pulmonary , metabolicendocrine , neurological , urogenital psychiatric disease judge investigator . Any condition require regular concomitant drug treatment , include herbal product , likely need concomitant drug treatment study . Susceptibility severe allergic reaction . Intake medication could affect outcome study within 2 week prior first study drug administration within less 5 time elimination halflife medication . Regular consumption 21 unit alcohol per week ( 1 unit = 4 cl spirit , 13 g alcohol ) . Current use nicotinecontaining product 5 cigarette equivalent/day . Inability refrain use nicotinecontaining product stay study centre . Inability refrain consume caffeinecontaining beverage first 24 hour treatment administration e.g . propensity experience headache abstain caffeinecontaining beverage . Blood donation loss significant amount blood within 2 month prior screen visit . Abnormal 12lead ECG find clinical relevance 10 min rest supine position screen visit HR &lt; 45 beats/minute &gt; 90 beats/minute 10 minute rest supine position screen visit . At screen visit , systolic BP &lt; 90 mmHg &gt; 140 mmHg 10 minute supine position , diastolic BP &lt; 50 mmHg &gt; 90 mmHg 10 minute supine position , symptomatic orthostatic hypotension , decrease ≥ 20 mmHg systolic BP decrease ≥ 10 mmHg diastolic BP 3 minute stand position . Abnormal 24hour Holter ECG record possible confirmed clinical relevance Any abnormal laboratory value , vital sign , physical examination finding , may opinion investigator interfere interpretation test result cause health risk subject take part study . Suspected current use illicit drug ( accord medical history enquiry physical examination ) , positive drug screen history longterm drug abuse . Positive serology human immunodeficiency virus antigen/antibodies ( HIVAgAb ) , hepatitis B virus surface antigen ( HBsAg ) hepatitis C virus antibody ( HCVAb ) . Participation another clinical drug study within 3 month prior first treatment administration study . Any condition opinion investigator would interfere evaluation result constitute health risk subject .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>Healthy volunteer</keyword>
</DOC>